Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>News>This Article

Thijn Brummelkamp Receives the EMBO Gold Medal for 2013

Published: Wednesday, May 08, 2013
Last Updated: Wednesday, May 08, 2013
Bookmark and Share
The award acknowledges his outstanding work to accelerate the genetic analysis of human disease.

In 2002, Brummelkamp developed an inexpensive method to permanently inactivate large numbers of genes by the use of RNA interference. This breakthrough involved the development of a new short hairpin RNA vector system (pSUPER) that directs the synthesis of small interfering RNAs in mammalian cells. The method is used today in many laboratories throughout the world and allows researchers to collect detailed information on the function and roles of the many human genes involved in diseases like cancer. The paper by Brummelkamp and colleagues in Science that describes the method has been cited more than 3500 times according to Thomson Reuters Web of Knowledge.

Brummelkamp and his research group also investigate how viruses and bacteria make their way into mammalian cells. The development of haploid genetic screens in Brummelkamp’s laboratory has permitted the identification of some of the proteins required for the entry of pathogens into mammalian cells. This method was recently used to demonstrate that the entry of the Ebola virus into human cells requires a protein involved in the transport of cholesterol. This type of work helps to identify new drug targets and is opening up novel approaches and strategies for the treatment of different viral and bacterial diseases.

“I am delighted and honoured to receive such a prestigious award and extremely grateful that I have been able to work with many fantastic scientists in stimulating environments over the years,” the prizewinner said upon hearing the news.

“Thijn Brummelkamp belongs to a rare breed of scientists that can influence a field of research not once but repeatedly,” commented Anton Berns, former director of research at the NKI. “He is expected to make many additional landmark contributions to molecular biology in the years to come,” stated EMBO Member Piet Borst from the NKI in his nomination letter.

In 2005, Brummelkamp was selected as one of the top innovators under the age of 35 in the United States by MIT Technology Review magazine.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Scientists Discover New Diagnostic Markers for Kawasaki Disease
Proteins discovered in human urine offers new opportunities for the diagnosis, study and treatment of disease.
Friday, December 21, 2012
Cancer Stem Cells Isolated from Kidney Tumours
Scientists have isolated cancer stem cells that lead to the growth of Wilms’ tumours, a type of cancer typically found in the kidneys of young children.
Friday, December 14, 2012
EMBO, EMBC and the National Science Council of Taiwan Sign Cooperation Agreement
New ways of global scientific interaction have been created following a cooperation agreement between EMBO, the European Molecular Biology Conference (EMBC), and the National Science Council of Taiwan (NSC).
Thursday, November 29, 2012
Scientific News
Promising Drug Candidate to Treat Chronic Itch
In a new study, scientists from the Florida campus of The Scripps Research Institute (TSRI) describe a class of compounds with the potential to stop chronic itch without the adverse side effects normally associated with medicating the condition.
Are Changes to Current Colorectal Cancer Screening Guidelines Required?
Editorial suggests more research is needed to pinpoint age to end aggressive screening.
Assessing Cancer Patient Survival and Drug Sensitivity
RNA editing events another way to investigate biomarkers and therapy targets.
New Molecular Marker for Killer Cells
Cell marker enables prognosis about the course of infections.
Potential Target for Treatment of Autism
Grant of $2.4 million will support further research.
Sniffing Out Cancer
Scientists have been exploring new ways to “smell” signs of cancer by analyzing what’s in patients’ breath.
Inroads Against Leukaemia
Potential for halting disease in molecule isolated from sea sponges.
Molecular ‘Kiss Of Death’ Flags Pathogens For Destruction
Researchers have discovered that our bodies mark pathogen-containing vacuoles for destruction by using a molecule called ubiquitin, commonly known as the "kiss of death."
A New Single-Molecule Tool to Observe Enzymes at Work
A team of scientists at the University of Washington and the biotechnology company Illumina have created an innovative tool to directly detect the delicate, single-molecule interactions between DNA and enzymatic proteins.
Milestone Single-Biomolecule Imaging Technique May Advance Drug Design
The first nanometer resolved image of individual tobacco mosaic virions shows the potential of low-energy electron holography for imaging biomolecules at a single particle level; a milestone in structural biology and a potential new tool for drug design.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos